NSRX Stock Analysis: Buy, Sell, or Hold?
NSRX - Nasus Pharma Ltd.
$3.15
-0.24 (-7.08%)
▼
5d:
+14.55%
30d:
+35.78%
90d:
-45.69%
BUY
MODERATE Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: Jun 24, 2026
Get Alerted When NSRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: NSRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: NSRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: NSRX is currently trading at $3.15, which is considered slightly high relative to its 30-day fair value range of $2.21 to $3.18.
Technical Outlook: Technically, NSRX is in a strong downtrend. Immediate support is located at $2.41, while resistance sits at $3.60. Short-term momentum is weak, with the stock down 7.1% recently.
Market Sentiment: NSRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $20.00 (+490.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NSRX is in a strong downtrend. Immediate support is located at $2.41, while resistance sits at $3.60. Short-term momentum is weak, with the stock down 7.1% recently.
Market Sentiment: NSRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $20.00 (+490.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$2.21 -
$3.18
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.7%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.1%)
- BULLISH: Trading 490.0% below Wall St target ($20.00)
Trading Range Analysis
30-Day Trading Range
$2.21 -
$3.18
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.41
Resistance Level
$3.60
Current Trend
Strong Downtrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.89
Wall Street Target
$20.00
(+490.0%)
Share & Embed Analysis
Last updated: May 08, 2026 4:44 PM ET
Data refreshes hourly during market hours. Next update: 5:44 PM
Data refreshes hourly during market hours. Next update: 5:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NSRX showing a specific setup today?
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
29 analysts |
$1202 | 59 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$158 | 60 HOLD |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$250 | 61 BUY |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$215 | 62 BUY |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$353 | 60 HOLD |